{
    "nctId": "NCT03024580",
    "briefTitle": "A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer",
    "officialTitle": "A Pilot Study Evaluating Megestrol Acetate Modulation in Advanced Breast Cancer With Positive Hormonal Receptor",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasm",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Progression free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Metastatic breast cancer with ER and/or PR positive (primary tumor)\n* Metastatic site amenable to biopsy\n\nExclusion Criteria:\n\n* Platelet count below 100,000 / mm3\n* Renal or hepatic impairment\n* Coagulation disorder",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}